Showing 3921-3930 of 9076 results for "".
- Analysis: PRS Improves Melanoma Risk Predictionhttps://practicaldermatology.com/news/tildrakizumab-matches-risankizumab-guselkumab-in-mid-term-psoriasis-outcomes/2486903/A polygenic risk score (PRS) improved prediction of invasive cutaneous melanoma when added to an established clinical risk model, according to findings from a recent genome-wide association analysis. The PRS was derived from a
- Dr. Miriam Bettencourt Speaks on Measles Resurgence and the Dermatologist’s Rolehttps://practicaldermatology.com/news/dr-miriam-bettencourt-speaks-on-measles-resurgence-and-the-dermatologists-role/2486877/As the ominous music from the “Mission Impossible” movies played over the speakers, a dramatic voice spoke: “Good morning, doctors. Sixty years of safe and effective vaccine has resulted in the eradication of measles. Recently, however, a distrust of science has pr
- BPO Not Linked with Higher Malignancy Risk: Meta-analysishttps://practicaldermatology.com/news/bpo-not-linked-with-higher-malignancy-risk-meta-analysis/2486846/Benzoyl peroxide (BPO) use for acne vulgaris was not significantly associated with increased malignancy risk in a systematic review and meta-analysis of more than 4 million patients, accoriding to results from a new meta-analysis.
- Imaging Bests Exam in Detecting Nodal Metastases in High-Risk cSCChttps://practicaldermatology.com/news/imaging-bests-exam-in-detecting-nodal-metastases-in-high-risk-cscc/2486802/Ultrasonography and computed tomography (CT) outperformed physical examination for detecting baseline nodal metastases in high-risk cutaneous squamous cell carcinoma (cSCC). Investigators for the prospective, multicenter diagnostic study evaluated baseline staging modalities for detecting
- CKD Linked to Higher Complication Risk After Mohs Surgeryhttps://practicaldermatology.com/news/ckd-linked-to-higher-complication-risk-after-mohs-surgery/2486676/Chronic kidney disease (CKD) was associated with increased postoperative complications following Mohs micrographic surgery (MMS), according to results of a study published as a Research Letter in the Journal of Drugs in Dermatology Authors evaluated
- Meta-Analysis: Similar AK Clearance With PDT and Cryotherapyhttps://practicaldermatology.com/news/meta-analysis-finds-similar-ak-clearance-with-pdt-and-cryotherapy/2486675/A recent systematic review and meta-analysis suggested comparable efficacy and safety of photodynamic therapy (PDT) and cryotherapy for lesion clearence in actinic keratosis (AK). The analysis, published in the Journal of
- Prediction Model Suggests Reduced Need for Laryngoscopy in Pemphigus Vulgarishttps://practicaldermatology.com/news/model-suggests-reduced-need-for-laryngoscopy-in-pemphigus-vulgaris/2486535/A new proposed clinical prediction model may identify low-risk patients who can safely defer laryngoscopy, reducing unnecessary procedures. Researchers for the retrospective cohort study from a tertiary dermatology center eval
- Early Inflammatory Signals May Precede Alopecia Areata Diagnosishttps://practicaldermatology.com/news/early-inflammatory-signals-may-precede-alopecia-areata-diagnosis/2486446/Data from a new systematic review presented at the 2026 American Academy of Dermatology Annual Meeting indicated a consistently elevated neutrophil-to-lymphocyte ratio (NLR) in alopecia areata (AA).Investigators used data from PubMed, Embase, and Cochrane
- Nicotinamide Linked to Reduced Melanoma Risk in VA Cohorthttps://practicaldermatology.com/news/nicotinamide-linked-to-reduced-melanoma-risk-in-va-cohort/2486445/Nicotinamide exposure was associated with a 25% reduction in melanoma incidence in a large VA cohort, according to data from a retrospective cohort study presented at the 2026 American Academy of Dermatology Annual Meeting. Investigators analyzed 30,741 pati
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://practicaldermatology.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De